PROMIS NEUROSCIENCES INC. Preferred Stock, Shares Outstanding
PROMIS NEUROSCIENCES INC. (PMN) had Preferred Stock, Shares Outstanding of 0 shares as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2024-11-14
- 2024-09-30: Preferred Stock, Shares Outstanding 0.00 shares.
- 2024-06-30: Preferred Stock, Shares Outstanding 1.17M shares.
- 2024-03-31: Preferred Stock, Shares Outstanding 1.17M shares.
- 2023-12-31: Preferred Stock, Shares Outstanding 1.17M shares.
| Period end | Preferred Stock, Shares Outstanding |
|---|---|
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 1.17M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 1.17M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 1.17M shares 10-Q · filed 2024-11-14 |
| 2023-09-30 | 70.00M shares 10-Q · filed 2023-11-14 |
| 2023-06-30 | 70.00M shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 70.00M shares 10-Q · filed 2023-05-15 |
| 2022-12-31 | 70.00M shares 10-Q · filed 2023-11-14 |
| 2022-09-30 | 70.00M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 70.00M shares 10-Q · filed 2022-08-12 |
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |